0001719252-18-000003.txt : 20180320 0001719252-18-000003.hdr.sgml : 20180320 20180320154029 ACCESSION NUMBER: 0001719252-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: 4a5 FILED AS OF DATE: 20180320 DATE AS OF CHANGE: 20180320 EFFECTIVENESS DATE: 20180320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ravenquest Biomed Inc. CENTRAL INDEX KEY: 0001719252 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-308135 FILM NUMBER: 18701802 BUSINESS ADDRESS: STREET 1: #2300 - 1177 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 2K3 BUSINESS PHONE: (604) 484-1230 MAIL ADDRESS: STREET 1: #2300 - 1177 WEST HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 2K3 D 1 primary_doc.xml X0708 D LIVE 0001719252 Ravenquest Biomed Inc. #2300 - 1177 WEST HASTINGS STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 2K3 (604) 484-1230 BRITISH COLUMBIA, CANADA Ravenquest Resources Inc. None Corporation true George Robinson #2300 - 1177 West Hastings Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Director CEO David Cross #2300 - 1177 West Hastings Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer CFO Anton Drescher #2300 - 1177 West Hastings Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Director Henk van Alphen #2300 - 1177 West Hastings Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Director Chris Bechtel #2300 - 1177 West Hastings Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Director Jorge Bonet #2300 - 1177 West Hastings Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Director Marla Ritchie #2300 - 1177 West Hastings Street Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Corporate Secretary Other Decline to Disclose 06b 4a5 false 2018-02-28 false true true true false 0 615777 615777 0 Based on Bank of Canada indicative exchange rate of CDN$0.7807 for USD$1.00 on February 28, 2018. false 3 0 0 0 false Ravenquest Biomed Inc. /s/ David Cross David Cross CFO 2018-03-20